Parth is a biotech industry executive with 15+ years of experience in end-to-end commercialization leadership. He has led programs/therapies from pipeline through launch and scale across oncology, rare disease, inflammation, and cardiovascular disease. His expertise spans new product planning, business development, US and global strategic marketing/market access, pricing, brand and sales leadership. As someone with a loved one with a rare disease, Parth is passionate about rare disease advocacy, innovation policy and non-profit healthcare initiatives. Parth holds a Doctorate in Pharmacy (PharmD) from USC and is a registered pharmacist with background across clinical, specialty and health plan settings. He also holds an MBA from USC Marshall School of Business, BS in Public Policy and BA in Biological Sciences from USC